Substance use in young adults with schizophrenic disorders.
about
Measuring readiness-to-change substance misuse among psychiatric outpatients: I. Reliability and validity of self-report measuresVulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Cannabis use and psychosis: a review of clinical and epidemiological evidence.Managing comorbid schizophrenia and substance abuse.The varied outcomes of schizophrenia.Perceived reasons for and consequences of substance abuse among patients with psychosisClinical correlates of maltreatment and traumatic experiences in childhood and adolescence among predominantly African American, socially disadvantaged, hospitalized, first-episode psychosis patients.Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns.Perceived reasons for substance misuse among persons with a psychiatric disorder.Desipramine enhances the ability of paliperidone to decrease alcohol drinking.Disappearing acts: the social networks of formerly homeless individuals with co-occurring disorders.Use of Legal Drugs by Psychiatric Outpatients: Benefits, Costs, and Change.HIV Risk Behavior among Outpatients at a State Psychiatric Hospital: Prevalence and Risk ModelingDrug Dependence and Psychotic Symptoms: A Retrospective Study of Adolescents Who Abuse Drugs at Al-Amal Hospital in Jeddah, Saudi Arabia.Substance abuse and lifestyle among an urban schizophrenic population: some observations.Prevalence of alcohol and drug abuse in schizophrenic inpatients.Detection of substance use disorders in severely mentally ill patients.Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence.Motives for substance use among young people seeking mental health treatment.Models of substance use in adolescents with and without psychosis.Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.Methods for studying course of illness with severely mentally ill adults.Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.Reasons for cannabis use in psychosis.Reasons for substance use in schizophrenia.Subjective effects of cannabis before the first psychotic episode.Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes.(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.Areas of skill training for persons with mental illness and substance use disorders: building skills for successful community living.Detection of alcoholism in schizophrenia using the MAST.Chronic schizophrenia: a risk factor for HIV?Awareness of substance abuse problems among dually-diagnosed psychiatric inpatients.An examination of the self-medication hypothesis via treatment completion
P2860
Q28361451-3DD6C583-E709-42C7-A7B4-6E0C56693C2FQ33664684-B1C619C2-F9B3-4B96-965F-284D46411C73Q33933884-C20D6227-4602-48E9-84DA-CE4B46185A66Q34370986-5823186D-9380-4214-8CEA-5217D80BD5A1Q34417104-0690F154-5B24-4D01-8576-ED60449B4ACCQ34516286-E75B8627-6C34-4778-AD01-3250879E9730Q35136605-1FD91F9A-43BC-498E-8C4B-96B4CB5D8441Q35529642-2125E282-047D-4761-9906-E8828E956B78Q35531488-52DA5782-6FDE-4CC2-B181-848483AFF438Q35677193-64FFF18E-EA71-4C4D-9134-17C16E397E1FQ36033815-90FBB870-C1E5-468D-A389-5DC12ABB7791Q36176189-CFE3AB11-9F35-46CF-ABA4-35A07E77DF01Q36712436-816F6FAB-F7FB-4406-B529-903495240479Q37269794-C189FBEA-7A92-447D-AC13-D0D0A3DD3E4BQ38904740-32A6672D-C00F-4E23-B498-65DB4E08695BQ39372312-37C9AE2C-D215-473F-9047-EB562C5C2C7DQ40821996-56760198-A996-4F5D-B45F-B2861F76EED1Q40910554-29E43184-7545-4248-9E9D-ABB7AA57FF0FQ40980949-A8C1E51A-9128-498F-8934-1E33E63F79B6Q42748636-DE0263D4-307E-4F14-8A14-D3DA4D03A6D6Q43242387-FDC429C5-3BA2-4A1D-8F41-356D69909B7CQ44819773-29CC98FF-3AB3-482C-8910-64DDFDCA76FDQ46663910-3B91C73D-3170-4645-B138-28F7C6F0C5D7Q48314627-4C8F203B-68BD-43A1-BF2E-8652F440C640Q48444646-B007358A-56A2-4337-B1E9-37B07844F7C2Q48735768-4051D03B-7B53-432D-920A-77CC0E740B25Q50716534-5F659193-6125-4182-B5F3-5B27CDE32E9FQ51913916-AEFAE58C-F606-46E1-9FA3-B95CD6C48A81Q51915805-4154B79B-10C5-4C2B-9BE4-ABD63274E536Q52028863-D5887F2E-9CCA-4455-88C4-729AD4D295DDQ52038088-6A3A3C82-AF75-411D-B628-F0561AD0C4E4Q52054537-EE09597D-9CA9-41C0-9177-B7C5E9F8CF98Q52277109-B3E09D6A-25C6-4B1E-80E3-249264C7599CQ58271545-7E4AB59A-5902-418C-A69E-090D72D27A5D
P2860
Substance use in young adults with schizophrenic disorders.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Substance use in young adults with schizophrenic disorders.
@en
Substance use in young adults with schizophrenic disorders.
@nl
type
label
Substance use in young adults with schizophrenic disorders.
@en
Substance use in young adults with schizophrenic disorders.
@nl
prefLabel
Substance use in young adults with schizophrenic disorders.
@en
Substance use in young adults with schizophrenic disorders.
@nl
P2093
P356
P1476
Substance use in young adults with schizophrenic disorders.
@en
P2093
P304
P356
10.1093/SCHBUL/15.3.465
P407
P577
1989-01-01T00:00:00Z